(c) 2024 PillSync.com

etodolac 400 mg

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac tablets are indicated: For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For the management of acute pain

Bayshore Pharmaceuticals, LLC


3 hours ago OVAL BROWN BY7 etodolac 400 mg

OVAL BROWN BY7

3 hours ago OVAL BROWN BY7 etodolac 400 mg

BY7 OVAL BROWN

HOW SUPPLIED

ETODOLAC tablets USP, 400 mg are available as beige colored, oval shaped tablets debossed BY7 on one side and plain on other side. - in bottles of 100 NDC 76385-118-01

ETODOLAC tablets USP, 500 mg are available as blue colored, oval shaped tablets debossed BY8 on one side and plain on other side. - in bottles of 100 NDC 76385-119-01 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Store tablets in original container until ready to use. Dispense in a tight, light-resistant container as defined in the USP, with a child resistant closure. Manufactured by: Aizant Drug Research Solutions Pvt. Ltd. Dulapally Village, Quthubullapur Mandal, Hyderabad, Telangana 500100, India. Distributed by: Bayshore Pharmaceuticals LLC. 788 Morris Turnpike, Suite 200, Short Hills, New Jersey 07078. Revised: 04/2021


More pills like OVAL BY7












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site